Screening Study to Determine Individuals With Potential Trial Eligibility for Alzheimer's Disease Studies

Recruiting now · Phase 3

Conditions studied: Alzheimers Disease

In brief

This study is a pre-screening process used to assess participants' potential eligibility for Roche interventional Alzheimer's disease studies.

Key facts

Study ID

NCT07177352

Run by

Hoffmann-La Roche

People needed

80000

Starts

2025-07-02

Expected to finish

2035-07-31

Last updated by the study team

2026-07-24

Who can join

Age: 50 and older, up to 90. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Ability and willingness to participate in an interventional clinical study, including meeting key eligibility criteria of linked interventional Roche AD studies (e.g., specific age ranges)
• Ability and willingness to receive information about potential eligibility in an associated interventional Roche AD study

You may not qualify if…

• Dependency in basic activities of daily living (bADLs) due to cognitive impairment
• Visual or auditory impairment that would prevent them from performing the cognitive assessments (eyeglasses and hearing aids are permitted)
• Any self-reported evidence or known diagnosis of a neurological or neurodegenerative condition that may lead to cognitive impairment other than AD
• History of severe, clinically significant central nervous system trauma
• Any serious medical condition that precludes a participant's safe participation and completion of a clinical study
• For participants with a clinical diagnosis of MCI or mild AD: Previous AD diagnosis based on biomarker confirmation with an approved or validated rule in method (e.g., amyloid PET or cerebrospinal fluid, blood biomarker) is exclusionary

Where it is running

• Banner Alzheimer?s Institute — Phoenix, Arizona, United States (enrolling)
• Banner Sun Health Research Institute — Sun City, Arizona, United States (enrolling)
• Sun Valley Research Center, Inc. — Imperial, California, United States (enrolling)
• Inglewood Clinicals — Inglewood, California, United States (enrolling)
• Irvine Center for Clinical Research — Irvine, California, United States (enrolling)
• Healthy Brain Clinic — Long Beach, California, United States (enrolling)
• Oakland Clinical — Oakland, California, United States (enrolling)
• Riverside Clinical — Riverside, California, United States (enrolling)
• Syrentis Clinical Research — Santa Ana, California, United States (enrolling)
• Cenexel California Neuroscience Research, LLC — Sherman Oaks, California, United States (enrolling)
• Yale University — New Haven, Connecticut, United States (enrolling)
• JEM Research LLC — Atlantis, Florida, United States (enrolling)
• K2 Medical Research-Winter Garden — Clermont, Florida, United States (enrolling)
• K2 Medical Research - The Villages — Lady Lake, Florida, United States (enrolling)
• K2 Medical Research, LLC — Maitland, Florida, United States (enrolling)
• Visionary Investigators Network- Neurology Aventura — Miami, Florida, United States (enrolling)
• Renstar Medical Research — Ocala, Florida, United States (enrolling)
• Charter Research - Winter Park/Orlando — Orlando, Florida, United States (enrolling)
• Conquest Research - Lake Nona — Orlando, Florida, United States (enrolling)
• Alzheimer's Research and Treatment Center — Stuart, Florida, United States (enrolling)
• Axiom Brain Health LLC — Tampa, Florida, United States (enrolling)
• Charter Research - Lady Lake/The Villages — The Villages, Florida, United States (enrolling)
• Alzheimer?s Research and Treatment Center — Wellington, Florida, United States (enrolling)
• Conquest Research, LLC — Winter Park, Florida, United States (enrolling)
• University of Alabama at Birmingham — Birmingham, Alabama, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.